Prestige Consumer Healthcare Inc.
NYSE:PBHMedical - Distribution
+$0.23 today
- Market cap
- $2.40B
- Beta
- 0.35
- P/E (TTM)
- 11.6
- EPS (TTM)
- $4.01
Volume 0.62M
Average 0.67M
PBH Net Income
Bottom-line profit, the starting point for calculating cash from operations.
Prestige Consumer Healthcare Inc.NYSE: PBH
Net Income · Q1 FY2027 · quarter ended Jun 2026
Net income declines year over year
Q1 FY2027 net income of $29.18M fell 38.5% year over year, behind the -19.2% change in trailing-twelve-month net income. Sequentially, it fell 45.9% from the prior quarter.
Context
- Net income amounted to 17.5% of revenue in FY2026, down 1.4 pp from a year earlier.
- Net income increased in 2 of the last 3 fiscal years.
What to watch
Whether net income reaches the consensus estimate from 6 analysts of $220.21M (+15.7%) for the fiscal year ending Mar 2027, a step up from the -11.3% reported in FY2026.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $29.18M-45.9% QoQ
- Last fiscal yearMar 2026
- $190.3M-11.3% YoY
- LTMJun 2026
- $172.01M-19.2% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -38.5% | +21.0% | +59.5 pp |
| 1 year | -11.3% | +15.7% | +27.0 pp |
| 3-year CAGR | — | +11.1% | — |
| 5-year CAGR | +9.1% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2026
- 190.3M USD
- Year-over-year change
- -11.3%
- 4-year CAGR
- -1.9%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | 190.3M | -11.3% |
| FY2025 | 2025-03-31 | 214.61M | +2.5% |
| FY2024 | 2024-03-31 | 209.34M | +354.3% |
| FY2023 | 2023-03-31 | (82.31M) | -140.1% |
| FY2022 | 2022-03-31 | 205.38M | — |
Net Income vs competitors
How PBH compares with its peers on the latest reported figures
- PBH's LTM Jun 2026 net income of $172.01M is the 6th largest of the 11 companies compared; the peer median is $12.66M.
- Its year-over-year change of -19.2% is the 8th highest of 11, against a peer median of +23.2%.
- Net income amounts to 15.6% of revenue for PBH, versus a peer median of 13.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
IRONDisc Medicine, Inc. | LTM Sep 2026 | $243.1M | +34.2% | +65.5% | — |
CONConcentra Group Holdings Parent, Inc. | LTM Sep 2026 | $226.7M | +45.1% | +0.1% | 9.7% |
| LTM Mar 2026 | $221.32M | +12.1% | +37.1% | 37.1% | |
| LTM Sep 2026 | $196.07M | +190.2% | +41.2% | 13.0% | |
| LTM Jun 2026 | $188.21M | -11.4% | -26.6% | 41.9% | |
| LTM Jun 2026 | $172.01M | -19.2% | — | 15.6% | |
| LTM Mar 2026 | $125.36M | -24.3% | -1.8% | 15.9% | |
HTFLHeartflow, Inc. Common Stock | LTM Sep 2026 | $79.02M | -37.0% | — | 33.1% |
| LTM Jun 2026 | $30.09M | +181.4% | — | 1.4% | |
| LTM Jun 2026 | $28.12M | +71.4% | — | 1.2% | |
| LTM Sep 2026 | $2.81M | -98.7% | -12.6% | 0.2% | |
| Peer median (excluding PBH) | $12.66M | +23.2% | +0.1% | 13.0% | |
Competitors are the stored peer set for PBH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Net Income | 205.38M | (82.31M) | 209.34M | 214.61M | 190.3M |
| Depreciation & Amortization | 32.09M | 32.63M | 30.68M | 30.17M | 31.27M |
| Deferred Income Tax | 9.98M | (60.77M) | 23.07M | 14.41M | 22.7M |
| Stock-Based Compensation | 9.04M | 12.41M | 14.01M | 11.16M | 10.84M |
| Change in Working Capital | (10.95M) | (53.86M) | (39.83M) | (41.94M) | (17.62M) |
| Accounts Receivables | (24.65M) | (24.93M) | (6.32M) | (16.33M) | (3.69M) |
| Inventory | 663K | (42.23M) | 24.44M | (9.31M) | (1.6M) |
| Accounts Payables | 9.15M | 7.26M | (24.97M) | (19.41M) | (151K) |
| Other Working Capital | 3.89M | 6.04M | (32.98M) | 3.11M | (12.19M) |
| Other Non-Cash Items | 14.38M | 381.61M | 11.66M | 23.11M | 20.14M |
| Operating Cash Flow | 259.92M | 229.72M | 248.93M | 251.52M | 257.63M |
| Capital Expenditures | (9.64M) | (7.78M) | (9.55M) | (8.22M) | (11.18M) |
| Acquisitions (Net) | (246.87M) | (3.8M) | (10.56M) | (9.23M) | (123.74M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | (1.93M) |
| Investing Cash Flow | (256.51M) | (11.58M) | (20.11M) | (17.45M) | (136.84M) |
| Debt Repayment | (5.58M) | (137.75M) | (227.83M) | (139.54M) | 504K |
| Common Stock Issued | 7.04M | 0 | 0 | 14.8M | 4.29M |
| Common Stock Repurchased | 0 | (50M) | (25M) | (51.51M) | (156.28M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (9.03M) | 1.91M | 11.81M | (5.83M) | (4.57M) |
| Financing Cash Flow | (7.57M) | (185.85M) | (241.02M) | (182.08M) | (156.06M) |
| Effect of Forex Changes | (959K) | (982K) | 180K | (573K) | 1.26M |
| Net Change in Cash | (5.12M) | 31.3M | (12.02M) | 51.42M | (34.02M) |
| Free Cash Flow | 250.28M | 221.93M | 239.38M | 243.29M | 246.45M |
Prestige Consumer Healthcare Inc.
NYSE:PBH
Intrinsic Alpha fair value
Locked
Current Price
$50.62
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.